Clinical and economic evaluation of pharmacotherapy of patients with tuberculosis in intensive therapy departments of antituberculosis dispensaries

Authors

  • I. O. Fedyak Ivano-Frankivsk National Medical University, Ukraine
  • I. H. Kupnovytska Ivano-Frankivsk National Medical University, Ukraine
  • N. R. Hrynyk Ivano-Frankivsk National Medical University, Ukraine

DOI:

https://doi.org/10.24959/sphhcj.18.114

Keywords:

tuberculosis, co-infection with TB/HIV/AIDS, life threatening complications of TB, intensive therapy, clinical economic analysis, frequency analysis, ABC-analysis

Abstract

Aim. To conduct the clinical and economic evaluation of the prescription leaflets of patients with complicated forms of tuberculosis and co-infection with TB / HIV.

Materials and methods. In the study 70 medical cards of inpatients with life-threatening complications of TB and TB/HIV/AIDS treated in six departments of anesthesiology and intensive therapy of regional anti-TB dispensaries of Ukraine were considered; such methods as retrospective clinical and economic: frequency / ABC analysis; analytical-synthetic; and graphic were used.

Results. In intensive therapy departments there were patients with TB (34 %) and TB/HIV/AIDS (66 %) with pulmonary insufficiency (37 %) and polyorganic insufficiency syndrome (simultaneously progressive disorders of hemostasis, acute respiratory distress syndrome, hepato-renal insufficiency – 19 %) with a chance to survive or die 51 % to 49 %. Most often the cause of death was cerebral edema (53 %) and multiple organ failure (23 %). On average, patients stayed 12 ± 11 bed-days in the departments; they had 1701 prescriptions with 223 medicines. The leaders in the frequency of prescriptions were: Analgin sol. for inj. 500 mg/ml, amp. 2 ml, No. 10, Yuria-Pharm; Dimedrol sol. For inj. 10 mg/ml, amp. 1 ml, No. 10, Darnitsa; Furosemide sol. for inj. 10 mg / ml, amp. 2 ml, No. 10, Zdorovia. The total cost of the pharmacotherapy consumed by patients was 3 574.95 UAH/for 1 patient.

Conclusions. The qualitative composition of pharmacotherapy taken by patients in the antituberculosis dispensaries needs to be improved on the model of the world standards: development of the Unified Protocol for providing medical care to patients with TB, co-infection of TB/HIV/AIDS with urgent states in intensive therapy departments is necessary.

Author Biographies

I. O. Fedyak, Ivano-Frankivsk National Medical University

Candidate of Pharmacy (PhD), associate professor of the Department of Organization and Economics of Pharmacy
and Drug Technology

I. H. Kupnovytska, Ivano-Frankivsk National Medical University

Doctor of Medicine (Dr. habil), professor, head of the Department of Clinical Pharmacology and
Pharmacotherapy

N. R. Hrynyk, Ivano-Frankivsk National Medical University

5rd year student of Pharmaceutical Faculty

References

World Health Organization. (2016). Global Tuberculosis Report 2016. WHO: Library Cataloguing-in-Publication Data. Available at: http://apps.who.int/iris/bitstream/handle/10665/250441/9789241565394-eng.pdf;jsessionid=933BC493963FC43F03DADBE2333B8BEB?sequence=1

World Health Organization. (2017). Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis. World Health Organization. Available at: http://apps.who.int/iris/bitstream/ handle/10665/259180/9789241512572-eng.pdf?sequence=1

Ariaiev, M., Kotova, N. (2015). Neonatolohiia, khirurhiia ta perynatalna medytsyna, 1, 90–93. Available at: http://nbuv.gov.ua/UJRN/Nkhpm_2015_5_1_21

MOZ Ukrainy. (2014). Nakaz vid 31.12.2014 No. 1039 “Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy doroslym. Ko-infektsiia (Tuberkuloz/VIL-infektsiia/SNID)”. Available at: http://www.moz.gov.ua/docfiles/dn_20141231_1039dod.pdf

Protsiuk, R. (2016). Tuberkuloz, lehenevi khvoroby, VIL-infektsiia, 1, 84–92.

MOZ Ukrainy. (2014). Nakaz vid 04.09.2014 No. 620 “Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy doroslym. Tuberkuloz”. Available at: http://mtd.dec.gov.ua/images/dodatki/ 2014_620_TB/ 2014_620_YKPMD_TB.pdf

Fomichova, N., Hritsova, N., Raznatovska, O., Klepikova, T. (2013). Tuberkuloz, lehenevi khvoroby, VIL-infektsiia, 3, 76–85.

Protsiuk, R. (2016). Tuberkuloz, lehenevi khvoroby, VIL-infektsiia, 3, 75–85.

Piatnochka, I., Kornaha, S., Piatnochka, V. (2016). Visnyk naukovykh doslidzhen, 2, 34–37.

Hritsova, N., Raznatovska, O. (2014). Tuberkuloz, lehenevi khvoroby, VIL-infektsiia, 1, 97–103.

MOZ Ukrainy. (2014). Nakaz vid 15.01.2014 No. 34 “Unifikovani klinichni protokoly ekstrenoi medychnoi dopomohy: Hipertermiia, Hipovolemichnii shok, Hostra dykhalna nedostatnist”. Available at: http://stomatologinfo.com/wp-content/uploads/2017/03/pdf.

Raznatovska, O., Bobrovnycha-Dvizova, Yu., Dvizov, O., Bendus, M., Fedchenko, T. (2012). Medychni perspektyvy, 3, 73–76. Available at: http://nbuv.gov.ua/UJRN/Mp_2012_17_3_15.

Reheda, M. (2013). Pleurisy. Lviv, 129.

Kotvitska, A., Krasulia, O., Kubarieva, I. (2012). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 6, 70–75.

Nemchenko, A., Balynska, M. (2016). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 3, 60–67. doi: 10.24959/uekj.16.27.

Panfilova, H., Tsurikova, O., Dorovskyi, O., Korzh, Yu. (2015). Klinichna farmatsiia, 4, 17–23.

Iakovlieva, L., Gerasymova, O., Horbachova, A., Krasiuk, A. (2015). Farmatsevtychnyi chasopys, 3, 83–87.

Iakovlieva, L., Mischenko, O., Gerasymova, O. (2015) Pharmacoeconomics: a self-study practice book for training students of speciality 8.110201 ”Pharmacy”. Kharkiv : NUPh, 94.

Fediak, I., Fediak, P. (2018). Sotsialna farmatsiia v okhoroni zdorovia, 1, 21–31. doi: 10.24959/sphhcj.18.103.

Published

2018-06-11

Issue

Section

Health organization